Vireo Growth Inc. reported significant financial growth in its latest quarterly filing, with total revenue reaching $209.3 million for the three months ended June 30, 2026, compared to $48.1 million for the same period in 2025, marking a 335% increase. For the first half of 2026, revenue totaled $315.5 million, up from $72.6 million in the prior year. The substantial growth is attributed to the company's strategic acquisitions, including Eaze and Vireo Health of Rocky Mountain, which expanded its retail and delivery capabilities in key markets such as California and Florida.
The company's gross profit for the second quarter was $95.3 million, resulting in a gross margin of 45.5%, compared to a gross profit of $20.4 million and a margin of 42.5% in the previous year. The increase in gross profit was driven by higher sales volumes and a decrease in non-cash product costs associated with inventory valuation adjustments. However, Vireo reported a net loss of $0.1 million for the quarter, a significant improvement from a loss of $14.9 million in the same quarter of 2025. For the first half of 2026, the net loss was $20.4 million, compared to a loss of $21.4 million in the prior year.
Operationally, Vireo has expanded its footprint significantly, now operating in ten states with a growing network of retail dispensaries. The company reported a notable increase in retail revenue, which reached $154.1 million in the second quarter, a 319% increase from $36.8 million in the same quarter of 2025. The wholesale segment also saw growth, with revenue increasing by 92% to $21.7 million. The Non-Cannabis segment, which includes the recently acquired Hawthorne and Bridgewell, contributed $33.5 million in revenue for the quarter, reflecting the company's diversification strategy.
In terms of strategic developments, Vireo completed several acquisitions in 2026, including the purchase of Hawthorne Gardening Company and Bridgewell Agribusiness, which have allowed the company to expand beyond cannabis into the horticultural and agricultural sectors. The company also underwent a share consolidation at a ratio of 30-for-1, effective June 5, 2026, which has been retroactively applied to all share and per-share amounts presented in the financial statements.
Looking ahead, Vireo Growth remains focused on leveraging its expanded operations to drive further revenue growth and improve profitability. The company anticipates that its strategic acquisitions will enhance its market position and operational efficiencies, while ongoing regulatory developments in the cannabis sector may provide additional opportunities for growth. The management's outlook reflects confidence in the company's ability to navigate the evolving market landscape and capitalize on its diversified business model.
About Vireo Growth Inc.
Vireo Growth Inc. is a vertically integrated cannabis company specializing in cultivation, manufacturing, and retail of high-quality cannabis products for medical and adult-use markets. Operating in Maryland, Minnesota, and New York, it produces proprietary strains, extracts, edibles, and topicals. The company owns dispensaries, develops innovative formulations, and emphasizes quality, safety, and community engagement within the evolving legal cannabis industry.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.
View the complete official filing on the SEC website.
Read on SEC.gov